Serial Number
88149295
Owner
Mezzion Pharma Co., Ltd.Attorney
Daniel R. MelloFiling Date
Oct 10, 2018
JURVIGO Trademark
Serial Number: 88149295 • Registration: 6311618
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
7F, 570 Samseong-ro, Gangnam-gu
Seoul 06163 , KR
Entity Type: 99
Legal Representation
Correspondence Address
Daniel R. Mello Finnegan, Henderson, Farabow, Garrett & Dunner LLP
901 New York Avenue NW
Washington, DC 20001
United States
Trademark Details
Filing Date
October 10, 2018
Registration Date
April 6, 2021
Published for Opposition
January 19, 2021
Goods & Services
Educational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues
Medical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease research, namely, single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others
Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
